Autoimmune Diseases  >>  toreforant (JNJ-38518168)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
toreforant (JNJ-38518168) / J&J
NCT01450982: A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants

Completed
1
20
US
JNJ-38518168 / MTX
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Rheumatoid Arthritis
 
10/11

Download Options